Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

CD16-IL15-CD33 Trispecific Killer Engager (TriKE) Overcomes Cancer-Induced Immune Suppression and Induces Natural Killer Cell-Mediated Control of MDS and AML Via Enhanced Killing Kinetics

Martin Felices, PhD, Dhifaf Sarhan, PhD, Ludwig Brandt, Karolin Guldevall, Ron McElmurry, Alexander Lenvik, Sami Chu, Jakub Tolar, MD PhD, Elizabeth Taras, Stephen R Spellman, MS, Erica D. Warlick, MD, Michael R. Verneris, MD, Sarah Cooley, MD, Daniel Weisdorf, MD, Bruce R. Blazar, MD, Bjorn Onfelt, PhD, Dan Vallera, PhD, Jeffrey S. Miller, MD

Blood (2016) 128 (22): 4291.

https://doi.org/10.1182/blood.V128.22.4291.4291

Published: 2016

Journal Articles

Comparison of Total Body Irradiation-Based with Intravenous Busulfan-Based Chemotherapy-Only Conditioning Regimens for Myeloablative Hematopoietic Cell Transplantation (HCT) in Adults with Acute Lymphoblastic Leukemia

Blood (2016) 128 (22): 679.

https://doi.org/10.1182/blood.V128.22.679.679

Published: 2016

Journal Articles

Immune Reconstitution (IR) after Allogeneic Hematopoietic Cell Transplantation (alloHCT): Comparing Results in Recipients of Unrelated Umbilical Cord Blood (UCB) to Those with an HLA-Matched Sibling Donor Peripheral Blood (MSD PB)

Nelli Bejanyan, MD, Claudio G Brunstein, MD, Qing Cao, M.S., Rohtesh S. Mehta, MD MPH, MS, Xianghua Luo, PhD, Julie Curtsinger, PhD, Sarah Cooley, MD, Bruce R. Blazar, MD, Jeffrey S. Miller, MD, Daniel Weisdorf, MD, John E. Wagner, MD, Michael R. Verneris, MD

Blood (2016) 128 (22): 4590.

https://doi.org/10.1182/blood.V128.22.4590.4590

Published: 2016

Journal Articles

Impact of Frailty on Hematopoietic Cell on Early Transplant Outcomes in Older Recipients

Mukta Arora, MD, Smita Bhatia, MD MPH, Todd E. DeFor, MS, Manju Nayar, Hewan Belete, MDcal student, Troy Lund, MD PhD, Bharat Thyagarajan, MDPhD, Celalettin Ustun, MD, Daniel Weisdorf, MD

Blood (2015) 126 (23): 388.

https://doi.org/10.1182/blood.V126.23.388.388

Published: 2015

Journal Articles

Physiologic Frailty Among Hematopoietic Cell Transplantation (HCT) Survivors Suggests Accelerated Aging and Is a Predictor for Premature Mortality: A Report from the Bone Marrow Transplant Survivor Study (BMTSS)

Mukta Arora, MD MS, Can-Lan Sun, PhD, Kirsten K. Ness, PhD, Jennifer Berano Teh, MD, Jessica Wu, Liton F. Francisco, BS, Saro Armenian, DO, MPH, Amy Schad, MPH, CCRP, Golnaz Namdar, MPH, Alysia Bosworth, Linus Kuo, Daniel Weisdorf, MD, Stephen J. Forman, MD, Smita Bhatia, MD MPH

Blood (2015) 126 (23): 739.

https://doi.org/10.1182/blood.V126.23.739.739

Published: 2015

Journal Articles

Autologous Transplant, and Not ATO Alone, Remains the Preferred Therapy for Relapsed APL: A Report from the CIBMTR, EBMT and Two Specialized Centers

Chezi Ganzel, Vikram Mathews, DM, Kamran Alimoghaddam, MD, Ardeshir Ghavamzadeh, MD, Deborah Kuk, ScM, Sean Devlin, PhD, Hailin Wang, Daniel Weisdorf, MD, Dan Douer, MD, Jacob M. Rowe, MD, Arnon Nagler, MD MSc, Mohamad Mohty, Martin S. Tallman, MD, Jordi Estev, Mei-Jie Zhang

Blood (2015) 126 (23): 928.

https://doi.org/10.1182/blood.V126.23.928.928

Published: 2015

Journal Articles

Outcome of Patients 65 Years and Older with Myelodysplastic Syndrome (MDS) Receiving Allogeneic Hematopoietic Stem Cell Transplantation Compared to Patients 55-64 Years of Age

Ehab Atallah, MD, Mary M. Horowitz, MD MS, Brent Logan, PhD, Min Chen, MS, Michael J. Boo, JD, Corey S Cutler, MD MPH, Joachim Deeg, MD, James L. Gajewski, MD, Dennis L. Confer, MD, Stephanie Farnia, MPH, Peter Greenberg, MD, Erica Warlick, MD, Daniel Weisdorf, MD, J. Douglas Rizzo, MD

Blood (2015) 126 (23): 193.

https://doi.org/10.1182/blood.V126.23.193.193

Published: 2015

Journal Articles

Comparison of Post-Allogeneic Hematopoietic Cell Transplantation (HCT) Outcomes after Matched Related Donor Versus Matched Unrelated Donor HCT in Adults with Acute Lymphoblastic Leukemia

Eric Segal, BS, Michael Martens, MS, Hai-Lin Wang, MPH, Ruta Brazauskas, PhD, Daniel Weisdorf, MD, Brenda M. Sandmaier, MD, Marcos J de Lima, MD, H. Jean Khoury, MD, Wael Saber, MD MS

Blood (2015) 126 (23): 2017.

https://doi.org/10.1182/blood.V126.23.2017.2017

Published: 2015

Journal Articles

Evidence for Heterogeneous Genetic Associations with Acute Lymphoblastic Leukemia (ALL) By Cytogenetics and Sex in High-Risk Patients Treated with Matched Unrelated Donor Allogeneic Blood or Marrow Transplant (URD-BMT)

Blood (2015) 126 (23): 2621.

https://doi.org/10.1182/blood.V126.23.2621.2621

Published: 2015

Journal Articles

Long-Term Health-Related Outcomes In Survivors Of Childhood Hematopoietic Cell Transplantation (HCT): A Report From The Bone Marrow Transplant Survivor Study (BMTSS)

Saro Armenian, D.O., M.P.H., Can-Lan Sun, PhD, Mukta Arora, MD, MS, K. Scott Baker, MD, MS, Liton Francisco, Joseph Rosenthal, MD, Daniel Weisdorf, MD, Stephen J. Forman, MD, Smita Bhatia, Ph.D.

Blood (2013) 122 (21): 553.

https://doi.org/10.1182/blood.V122.21.553.553

Published: 2013

Journal Articles

Allele Level HLA Matching On Outcomes After Double Umbilical Cord Blood (dUCB) Transplantation for Hematological Malignancies: Stronger Graft Vs. Leukemia with HLA Mismatch

Claudio G Brunstein, MD, Todd E. Defor, MS, Harriet Noreen, CHS, David Maurer, Margaret L. MacMillan, MD, Michael R. Verneris, MD, Phillip McGlave, MD, Daniel Weisdorf, MD, John E. Wagner, MD

Blood (2012) 120 (21): 1976.

https://doi.org/10.1182/blood.V120.21.1976.1976

Published: 2012

Journal Articles

The Outcome of Hematopoietic Cell Transplantation (HCT) for Myelodysplastic Syndrome (MDS) in Adults ≥65 Years of Age: First Report of the Coverage with Evidence Development (CED) in Medicare Beneficiaries

Ehab Atallah, MD, Tanya L. Pedersen, MPH, Erica D. Warlick, MD, Anne Dircks, BS, CCRP, Daniel Weisdorf, MD, Mary M. Horowitz, MD, MS, J. Douglas Rizzo, MD

Blood (2012) 120 (21): 1983.

https://doi.org/10.1182/blood.V120.21.1983.1983

Published: 2012

Journal Articles

Increased Relapse Associated with Mixed Donor-Donor Chimerism Following Double Umbilical Cord Blood Transplantation (dUCBT)

Michael R. Verneris, MD, Lucie M. Turcotte, MD, Qing Cao, MS, Margaret L. MacMillan, MD, Jeffrey S. Miller, MD, Daniel Weisdorf, MD, Claudio G Brunstein, MD, John E. Wagner, MD

Blood (2012) 120 (21): 358.

https://doi.org/10.1182/blood.V120.21.358.358

Published: 2012

Journal Articles

Elevated Absolute Lymphocyte Counts Following Acute Graft Vs. Host Disease Treatment Is Associated with Therapeutic Responses and Lower Non-Relapse Mortality Following Umbilical Cord Blood Transplant,

Michael R Verneris, MD, Sanyukta Janardan, BS, Michael J Burke, MD, Todd E. Defor, MS, Claudio Brunstein, MD, Bruce R. Blazar, MD, Jeffrey S. Miller, MD, John E. Wagner, MD, Daniel Weisdorf, MD, Margaret L. MacMillan, MD

Blood (2011) 118 (21): 4085.

https://doi.org/10.1182/blood.V118.21.4085.4085

Published: 2011

Journal Articles

Late Hospitalizations in Long-Term Survivors of Hematopoietic Cell Transplantation (HCT): Report From the Bone Marrow Transplant Study (BMTSS).

Melanie D Sabado, Can-Lan Sun, Liton Francisco, K. Scott Baker, Daniel Weisdorf, MD, Stephen J. Forman, MD, Smita Bhatia

Blood (2009) 114 (22): 807.

https://doi.org/10.1182/blood.V114.22.807.807

Published: 2009

Journal Articles

Comparison of Two Mycophenolate Mofetil Dosing Regimens Following Hematopoietic Cell Transplantation (HCT).

Pamala A. Jacobson, PharmD, Sheiren Farag El-Massah, John Rogosheske, PharmD, Amber Kerr, RN, Janel Boyle-Long, PharmD, Todd DeFor, MS, Cathryn Jennisen, PharmD, Claudio Brunstein, MD, John E. Wagner, MD, Marcie Tomblyn, MD, Daniel Weisdorf, MD

Blood (2008) 112 (11): 1116.

https://doi.org/10.1182/blood.V112.11.1116.1116

Published: 2008

Journal Articles

Fludarabine Exposure Is Associated with Increased Treatment Related Mortality after Nonmyeloablative Hematopoietic Cell Transplantation (HCT)

Pamala A. Jacobson, Pharmd, Janel R Long, PharmD, John Rogosheske, PharmD, Kathleen Green, PharmD, Claudio Brunstein, MD, John E Wagner, MD, Qing Cao, MS, Jeffrey S. Miller, MD, Philip McGlave, MD, Daniel Weisdorf, MD

Blood (2008) 112 (11): 795.

https://doi.org/10.1182/blood.V112.11.795.795

Published: 2008

Journal Articles

Negative Effect of KIR Alloreactivity in Recipients of Umbilical Cord Blood Transplantation Depends on Transplantation Conditioning Intensity

Claudio Brunstein, MD, PhD, John E. Wagner, MD, Daniel Weisdorf, MD, Sarah Cooley, MD, Harriet Noreen, Juliet Barker, MBBS, Todd DeFor, Michael Verneris, MD, Philip B. McGlave, Bruce R. Blazar, MD, Jeffrey S. Miller, MD

Blood (2008) 112 (11): 152.

https://doi.org/10.1182/blood.V112.11.152.152

Published: 2008

Journal Articles

Activating KIR (B Haplotype) in Unrelated Donors Improves Disease-Free Survival after HLA-Matched and Mismatched Allogeneic Transplantation for Acute Myeloid Leukemia: Implications for Donor Selection Using KIR Genotyping.

Sarah Cooley, MD, Jeffrey S. Miller, MD, Elizabeth Trachtenberg, PhD, Tracy Bergemann, PhD, Koy Saeteurn, John Klein, PhD, Lisbeth A. Guethlein, Steven G.E. Marsh, PhD, Daniel Geraghty, PhD, Peter Parham, PhD, Daniel Weisdorf, MD

Blood (2007) 110 (11): 43.

https://doi.org/10.1182/blood.V110.11.43.43

Published: 2007

Journal Articles

Pharmacogenetics of Mycophenolate Mofetil in Patients Undergoing Hematopoietic Cell Transplantation (HCT).

Janel Long, PharmD, William S. Oetting, PhD, Wang Xinjing, MD, PhD, Xianghua Luo, PhD, Marcie Tomblyn, MD, Daniel Weisdorf, MD, Pamala Jacobson, PharmD

Blood (2007) 110 (11): 3010.

https://doi.org/10.1182/blood.V110.11.3010.3010

Published: 2007

NARROW

CD16-IL15-CD33 Trispecific Killer Engager (TriKE) Overcomes Cancer-Induced Immune Suppression and Induces Natural Killer Cell-Mediated Control of MDS and AML Via Enhanced Killing Kinetics

Comparison of Total Body Irradiation-Based with Intravenous Busulfan-Based Chemotherapy-Only Conditioning Regimens for Myeloablative Hematopoietic Cell Transplantation (HCT) in Adults with Acute Lymphoblastic Leukemia

Immune Reconstitution (IR) after Allogeneic Hematopoietic Cell Transplantation (alloHCT): Comparing Results in Recipients of Unrelated Umbilical Cord Blood (UCB) to Those with an HLA-Matched Sibling Donor Peripheral Blood (MSD PB)

Impact of Frailty on Hematopoietic Cell on Early Transplant Outcomes in Older Recipients

Physiologic Frailty Among Hematopoietic Cell Transplantation (HCT) Survivors Suggests Accelerated Aging and Is a Predictor for Premature Mortality: A Report from the Bone Marrow Transplant Survivor Study (BMTSS)

Autologous Transplant, and Not ATO Alone, Remains the Preferred Therapy for Relapsed APL: A Report from the CIBMTR, EBMT and Two Specialized Centers

Outcome of Patients 65 Years and Older with Myelodysplastic Syndrome (MDS) Receiving Allogeneic Hematopoietic Stem Cell Transplantation Compared to Patients 55-64 Years of Age

Comparison of Post-Allogeneic Hematopoietic Cell Transplantation (HCT) Outcomes after Matched Related Donor Versus Matched Unrelated Donor HCT in Adults with Acute Lymphoblastic Leukemia

Evidence for Heterogeneous Genetic Associations with Acute Lymphoblastic Leukemia (ALL) By Cytogenetics and Sex in High-Risk Patients Treated with Matched Unrelated Donor Allogeneic Blood or Marrow Transplant (URD-BMT)

Long-Term Health-Related Outcomes In Survivors Of Childhood Hematopoietic Cell Transplantation (HCT): A Report From The Bone Marrow Transplant Survivor Study (BMTSS)

Allele Level HLA Matching On Outcomes After Double Umbilical Cord Blood (dUCB) Transplantation for Hematological Malignancies: Stronger Graft Vs. Leukemia with HLA Mismatch

The Outcome of Hematopoietic Cell Transplantation (HCT) for Myelodysplastic Syndrome (MDS) in Adults ≥65 Years of Age: First Report of the Coverage with Evidence Development (CED) in Medicare Beneficiaries

Increased Relapse Associated with Mixed Donor-Donor Chimerism Following Double Umbilical Cord Blood Transplantation (dUCBT)

Elevated Absolute Lymphocyte Counts Following Acute Graft Vs. Host Disease Treatment Is Associated with Therapeutic Responses and Lower Non-Relapse Mortality Following Umbilical Cord Blood Transplant,

Late Hospitalizations in Long-Term Survivors of Hematopoietic Cell Transplantation (HCT): Report From the Bone Marrow Transplant Study (BMTSS).

Comparison of Two Mycophenolate Mofetil Dosing Regimens Following Hematopoietic Cell Transplantation (HCT).

Fludarabine Exposure Is Associated with Increased Treatment Related Mortality after Nonmyeloablative Hematopoietic Cell Transplantation (HCT)

Negative Effect of KIR Alloreactivity in Recipients of Umbilical Cord Blood Transplantation Depends on Transplantation Conditioning Intensity

Activating KIR (B Haplotype) in Unrelated Donors Improves Disease-Free Survival after HLA-Matched and Mismatched Allogeneic Transplantation for Acute Myeloid Leukemia: Implications for Donor Selection Using KIR Genotyping.

Pharmacogenetics of Mycophenolate Mofetil in Patients Undergoing Hematopoietic Cell Transplantation (HCT).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only